BELKIN Vision is developing an automated, fast glaucoma laser device, aimed at revolutionizing accessibility to glaucoma care worldwide.
Business Model:
Revenue: $0
Employees: 11-50
Address: 13 Gan Raveh Street
City: Yavne
State: center district
Zip: 8122214
Country: IL
BELKIN Vision is developing an automated, fast glaucoma laser treatment, aimed at revolutionizing accessibility to glaucoma care by becoming the first-line choice for glaucoma therapy for every patient, all over the world. BELKIN Vision is addressing the growing disparity between the enormous number of glaucoma patients (67M) and the limited number of ophthalmologists (212,000), by enabling the doctor to treat many more patients quickly. BELKIN’s innovative technology is applicable for the prevalent Open Angle Glaucoma (OAG, 70% of total glaucoma patients) and it will pioneer laser treatment for Angle Closure Glaucoma (ACG, 30%), which is most common among Asian populations. • The innovative solution provides treatment that is patient friendly - non-invasive, non-contact, instantaneous &a; painless. • BELKIN Laser has the opportunity to completely transform the conventional glaucoma treatment from a specialized procedure performed mainly by glaucoma specialists, into a treatment that is effective, safe and reliable which can be carried out by all ophthalmologists and other healthcare providers.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2020 | Series B | $12.5M |
Rimonci Capital C-Mer Eye Care Holdings |
6/2017 | Equity | $5.3M |
Zico Holdings |
12/2021 | Grant | 1 | $19.7M |
European Innovation Council European Innovation Council |
7/2020 | Series B | 5 | $12.3M |
BioLight Israeli Life Sciences Investments Ltd C-Mer Eye Care Holdings CR-CP Life Science Fund Rimonci Capital Santen Ventures BioLight Israeli Life Sciences Investments Ltd C-Mer Eye Care Holdings CR-CP Life Science Fund Rimonci Capital Santen Ventures |
6/2017 | Series A | 4 | $6.6M |
European Union RAD BioMed Accelerator Rimonci Capital Zicom Holdings European Union RAD BioMed Accelerator Rimonci Capital Zicom Holdings |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|